A study with U87 cells and GBM xenografts has shown that GLS inhibition sensitizes to mTOR inhibitors by blocking the enhanced glutamine metabolism induced as a compensatory reaction against mTOR inhibition [66]. Here, MTOR is linked to glioblastoma.